TG Therapeutics, Inc.
787 Seventh Avenue
48th Floor
New York
New York
10019
United States
Tel: 212-554-4484
Fax: 212-554-4531
Website: http://www.tgtherapeutics.com/
Email: ir@tgtxinc.com
402 articles about TG Therapeutics, Inc.
-
TG Therapeutics, Inc. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
9/8/2014
-
TG Therapeutics, Inc. Announces Novel "Chemo-Free" Triple Therapy Combination Clinical Study For Patients With Chronic Lymphocytic Leukemia And Other B-Cell Malignancies
8/15/2014
-
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results And Business Update
7/22/2014
-
TG Therapeutics, Inc. Completes Global Licensing Agreement With Ligand Pharmaceuticals Inc. For The Development Of Inhibitors Of IRAK4
6/24/2014
-
TG Therapeutics, Inc. To Present At The 2014 JMP Securities Healthcare Conference
6/23/2014
-
TG Therapeutics, Inc. To Present At The 2014 Wells Fargo Healthcare Conference
6/17/2014
-
TG Therapeutics, Inc.' TG-1101 (Ublituximab) In Combination With Ibrutinib Demonstrates Compelling Clinical Activity And Safety Profile In Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) And Mantle Cell Lymphoma (MCL)
6/13/2014
-
TG Therapeutics, Inc. Announces Clinical Data Presentations For TG-1101 And TGR-1202 At The European Hematology Association Meeting In Milan, Italy
5/23/2014
-
TG Therapeutics, Inc. To Host Conference Call On First Quarter 2014 Financial Results And Business Update
5/9/2014
-
TG Therapeutics, Inc. Provides Update On A Modified TGR-1202 Formulation And Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure
5/8/2014
-
TG Therapeutics, Inc. Announces Clinical Data Presentations At Upcoming Conferences
5/6/2014
-
TG Therapeutics, Inc. To Present At The 39th Annual Deutsche Bank Healthcare Conference
5/5/2014
-
TG Therapeutics, Inc. Announces Preclinical Poster Presentations For TGR-1202 At American Association for Cancer Research 2014
4/7/2014
-
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale Of Common Stock To A Single Institutional Investor
3/12/2014
-
TG Therapeutics, Inc. To Present At The 26th Annual ROTH Conference
3/10/2014
-
TG Therapeutics, Inc. Announces Fourth Quarter And Year-End 2013 Financial Results And Business Update
3/6/2014
-
TG Therapeutics, Inc. To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/10/2014
-
TG Therapeutics, Inc. To Present At The 32nd Annual J.P. Morgan Healthcare Conference
1/14/2014
-
TG Therapeutics, Inc. Announces Presentation Of Encouraging Clinical Activity Of TGR-1202 In An Ongoing Multi-Center Phase I Clinical Study
12/9/2013
-
TG Therapeutics, Inc. Launches Combination Clinical Trial Of TG-1101 And Ibrutinib In Patients With Select B-Cell Malignancies
12/6/2013